The global drug screening laboratory services market was valued at $6,720.43 million in 2019, and is projected to reach $7,050.91 million by 2027, registering a CAGR of 9.4% from 2020 to 2027.
Drug screening is a quick and painless technical analysis of biological samples such as blood, hair, and urine to diagnose presence of illegal, prescription drugs, or its metabolites. Drug screening devices have improved, owing to the introduction of new technologies that offer users with precise and accurate results. Drug screening tests are adopted by employers to maintain a free, healthy, and sober workforce that helps maintain high productivity and an appropriate work environment. Rise in alcohol consumption among youth & elderly population, increase in use of narcotics & illicit drugs at workplace, and over use of prescribed drugs are the key factors that fuel growth of the drug screening laboratory services market. Moreover, technological advancements in drug screening products, surge in applications of these services, and increase in competition among providers boost growth of the global market. Furthermore, rise in government funding & initiatives for drug testing, increase in patient awareness toward drug screening policies, and adverse effects of drugs & alcohol are other factors that contribute toward growth of the market. However, possible manipulation of drug screening tests, and poor demand in under developed countries are expected to hinder growth of the market.
The drug screening laboratory services market is segmented into service type, sample type, end user, and region. On the basis of service, the market is categorized into workplace drug testing and clinical toxicology. By sample type, it is further divided into urine, oral fluid, breath, hair, and others. On the basis of end user, it is divided into retail, oil & gas, transportation, staffing, government, other workplaces, hospital laboratories, clinical laboratories, and other laboratories. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS

? The study provides an in-depth analysis of the global drug screening laboratory services market along with the current trends and future estimations to elucidate the imminent investment pockets.
? A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
? Comprehensive quantitative analysis of the industry from 2019 to 2027 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
? Extensive analysis of the key segments of the industry helps to understand the application and products of drug screening used across the globe.
? Key market players and their strategies have been analysed to understand the competitive outlook of the drug screening laboratory services market.

KEY MARKET SEGMENTS
By Service Type
- Workplace Drug Testing
- Clinical Toxicology Testing
By Sample Type
- Urine Sample
- Oral Fluid Sample
- Hair Sample
- Others
By End User
- Retail
- Oil and Gas
- Transportation
- Staffing
- Government
- Other Workplaces
- Hospital Laboratories
- Clinical Laboratories
- Other Laboratories


By Region
- North America
o U.S.
o Canada
o Mexico
- Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe


KEY MARKET PLAYERS
- Abbott Laboratories (Alere Inc.)
- Acm Global Laboratories, Inc
- Clinical Reference Laboratory
- Quest Diagnostics Incorporated.
- Laboratory Corporation Of America Holdings
- Psychemedics
- Millennium Health
- Mayo Laboratories For Medical Education and Research
- Omega Laboratories
- Precision Diagnostics
- Cordant Health Solutions